Timothy Andrew Woods

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignees: Eli Lilly and Company, Elanco US Inc., Warner-Lambert Company. Active years: 2011-2025.

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 50.0

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 7)

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 53(Granted Patents)

Location History:

Remington, IN (US) (2011 - 2013)
Edinburgh, IN (US) (2014 - 2023)

Company Filing History:

5 out of 4,509

Eli Lilly and Company

Warner-Lambert Company

Years Active: 2011-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12234239 - Crystalline forms of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile (2025-02-25),

2. 11548895 - Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile (2023-01-10),

3. 10323019 - Pyrazolylaminobenzimidazole derivatives as JAK inhibitors (2019-06-18),

4. 9790177 - Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) (2017-10-17),

5. 9624218 - Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors (2017-04-18),

6. 9522923 - Selective BACE1 inhibitors (2016-12-20),

7. 9156824 - CDC7 inhibitors (2015-10-13),

8. 8648200 - Imidazole derivatives useful for the treatment of arthritis (2014-02-11),

9. 8563750 - Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylmino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) (2013-10-22),

10. 8026376 - Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoicacid calcium salt (2:1) (2011-09-27),

Title: The Innovative Contributions of Timothy Andrew Woods

Introduction

Timothy Andrew Woods is a notable inventor based in Edinburgh, Indiana, known for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, Woods has made remarkable advancements in the development of crystalline forms of various compounds.

Latest Patents

Woods' latest patents include the crystalline forms of 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile. The present disclosure provides not only the crystalline forms but also pharmaceutical compositions comprising these forms, methods of using them, and processes for their production. Additionally, he has developed a process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile, further enhancing the pharmaceutical applications of this compound.

Career Highlights

Throughout his career, Woods has worked with prominent companies in the pharmaceutical industry, including Eli Lilly and Company and Warner-Lambert Company. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in drug formulation.

Collaborations

Woods has collaborated with talented individuals such as Aeri Park and Jingdan Hu, further enriching his work and expanding the impact of his inventions.

Conclusion

Timothy Andrew Woods exemplifies the spirit of innovation in the pharmaceutical industry through his extensive patent portfolio and collaborative efforts. His work continues to influence the development of new pharmaceutical compositions and methods, showcasing the importance of inventors in advancing healthcare solutions.